Skip to content

Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception

Recovery of Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception: Is the Recovery Period Related to AMH?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02785809
Enrollment
50
Registered
2016-05-30
Start date
2016-04-30
Completion date
2020-03-31
Last updated
2016-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMH, Long-term Use, Oral Contraceptives, Ovarian Reserve Parameters

Keywords

Oral contraceptives, long-term use, AMH, Ovarian reserve parameters

Brief summary

The aim of this study is to investigate whether there is a correlation between anti-Müllerian hormone during long-term use of combined oral contraceptives and the recovery time before recovered menstrual cycle after discontinuation of oral contraceptives.

Detailed description

Background: Hormonal contraception is widely used among women worldwide; 50-89% of all women in the Western countries use oral contraception at some point in their lives. Oral contraceptives (OC) suppress the hypothalamic-pituitary-ovarian axis through a negative feedback of ethinyl estradiol and progestins and thereby potentially influence the markers of ovarian reserve due to a suppressed release of gonadotropins, which will impair the growth of antral follicles. Methods and Materials: Participants for this studies will be included through the Fertility Assessment and Counseling Clinic, Rigshospitalet, Herlev- and Hvidovre Hospital. Inclusion criteria: Use of oral contraception (for study 3 at least during the last three years). Exclusion criteria: Known infertility, known thyroid disease. Aims: Study 3: Investigate the ovarian reserve markers after discontinuation of OC over a period of three months in women with a history of long-term OC use. The women will be followed with serial ultrasounds and blood samples and will complete a menstrual calendar.

Interventions

OTHERPausing oral contraceptive

Sponsors

Hvidovre University Hospital
CollaboratorOTHER
Herlev Hospital
CollaboratorOTHER
Anders Nyboe Andersen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
26 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Minimum three years of oral contraceptives.

Exclusion criteria

* Known infertility, known thyroid disease.

Design outcomes

Primary

MeasureTime frame
Time for recovered menstrual cycle after discontinuation of oral contraception6 months after discontinuation
Ovarian reserve parameters before and after discontinuation of combined oral contraception3 months after discontinuation

Secondary

MeasureTime frame
Correlation between suppression of the pituitary gonodal axis during use of oral contraceptives and time for recovered menstrual cycle3 months

Countries

Denmark

Contacts

Primary ContactSelma K Landersoe, MD
selma.kloeve.landersoe.01@regionh.dk+45 35 45 49 51
Backup ContactAnders N Andersen, Professor, MD
anders.nyboe.andersen@regionh.dk+45 35 45 13 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026